Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback